Effects of genetic variants on platelet reactivity and one-year clinical outcomes after percutaneous coronary intervention: A prospective multicentre registry study

Clopidogrel is the mainstay for antiplatelet treatment after percutaneous coronary intervention (PCI). The relationship of platelet reactivity and genetic polymorphism with clinical outcomes with newer-generation drug-eluting stents is unclear. We analysed 4,587 patients for the most powerful single...

Descripción completa

Detalles Bibliográficos
Autores principales: Joo, Hyung Joon, Ahn, Sung Gyun, Park, Jae Hyoung, Park, Ji Young, Hong, Soon Jun, Kim, Seok-Yeon, Choi, WoongGil, Gwon, HyeonCheol, Lim, Young-Hyo, Kim, Weon, Kang, Woong Chol, Cho, Yun-Hyeong, Kim, Yong Hoon, Yoon, JungHan, Shin, WonYong, Hong, Myeong-Ki, Garg, Scot, Jang, Yangsoo, Lim, Do-Sun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775197/
https://www.ncbi.nlm.nih.gov/pubmed/29352151
http://dx.doi.org/10.1038/s41598-017-18134-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775197/
https://www.ncbi.nlm.nih.gov/pubmed/29352151
http://dx.doi.org/10.1038/s41598-017-18134-y

Ejemplares similares